U.S. flag

An official website of the United States government

NM_033380.3(COL4A5):c.1397G>A (p.Gly466Glu) AND multiple conditions

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 5, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001257274.10

Allele description [Variation Report for NM_033380.3(COL4A5):c.1397G>A (p.Gly466Glu)]

NM_033380.3(COL4A5):c.1397G>A (p.Gly466Glu)

Gene:
COL4A5:collagen type IV alpha 5 chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq22.3
Genomic location:
Preferred name:
NM_033380.3(COL4A5):c.1397G>A (p.Gly466Glu)
HGVS:
  • NC_000023.11:g.108591618G>A
  • NG_011977.2:g.156695G>A
  • NM_000495.5:c.1397G>A
  • NM_033380.3:c.1397G>AMANE SELECT
  • NP_000486.1:p.Gly466Glu
  • NP_203699.1:p.Gly466Glu
  • LRG_232t1:c.1397G>A
  • LRG_232t2:c.1397G>A
  • LRG_232:g.156695G>A
  • LRG_232p1:p.Gly466Glu
  • LRG_232p2:p.Gly466Glu
  • NC_000023.10:g.107834848G>A
  • NG_011977.1:g.156695G>A
  • NM_033380.2:c.1397G>A
  • P29400:p.Gly466Glu
Protein change:
G466E
Links:
UniProtKB: P29400#VAR_001936; dbSNP: rs104886114
NCBI 1000 Genomes Browser:
rs104886114
Molecular consequence:
  • NM_000495.5:c.1397G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033380.3:c.1397G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hematuria
Identifiers:
MedGen: C0018965; Human Phenotype Ontology: HP:0000790
Name:
Microscopic hematuria
Synonyms:
Microhematuria
Identifiers:
MedGen: C0239937; Human Phenotype Ontology: HP:0002907

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001433818Centre for Mendelian Genomics, University Medical Centre Ljubljana
criteria provided, single submitter

(ACMG guidelines, Richards 2015)		Likely pathogenic
(Nov 5, 2019) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss.

Oza AM, DiStefano MT, Hemphill SE, Cushman BJ, Grant AR, Siegert RK, Shen J, Chapin A, Boczek NJ, Schimmenti LA, Murry JB, Hasadsri L, Nara K, Kenna M, Booth KT, Azaiez H, Griffith A, Avraham KB, Kremer H, Rehm HL, Amr SS, Abou Tayoun AN; et al.

Hum Mutat. 2018 Nov;39(11):1593-1613. doi: 10.1002/humu.23630.

PubMed [citation]
PMID:
30311386
PMCID:
PMC6188673

Details of each submission

From Centre for Mendelian Genomics, University Medical Centre Ljubljana, SCV001433818.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS4_MOD,PM1,PM2,PP2,PP3. This variant was detected in heterozygous state.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024